[Principles of anticoagulant therapy in myocardial infarct].
D000208:Acute Disease; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D004347:Drug Interactions; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008297:Male; D008833:Microcirculation; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000209:etiology; D010973:Platelet Adhesiveness / Q000187:drug effects; D011517:Prothrombin Time; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014665:Vasodilator Agents; D006886:Hydroxychloroquine
Podstawy postepowania przeciwzakrzepowego w zawale serca.